Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Levine
    Levine
  2. Mauro
    Mauro
  3. Stein
    Stein
  4. Rampal
    Rampal
  5. Abdel-Wahab
    Abdel-Wahab
  6. Devlin
    Devlin
  7. Park
    Park
  8. Sadelain
    Sadelain
  9. Wang
    Wang
  10. Berman
    Berman

Groups

  1. Adult Leukemia (99)
  2. Center for Hematologic Malignancies (99)
  3. Department of Medicine (99)
  4. Hematologic Malignancies, Division of (99)
  5. GSK Faculty (33)
  6. Executive Committee, Center for Hematologic Malignancies (26)
  7. Human Oncology and Pathogenesis Program (26)
  8. Sloan Kettering Institute Postdocs (11)
  9. Tow Center for Developmental Oncology (TCDO) (11)
  10. Biostatistics Service (9)
Search Within
  1. "Adult Leukemia"
Formats
  1. Meeting Abstract (53)
  2. Journal Article (33)
  3. Research Letter (7)
  4. Editorial (4)
  5. Review (2)
Groups
  1. Adult Leukemia (99)
  2. Center for Hematologic Malignancies (99)
  3. Department of Medicine (99)
  4. Hematologic Malignancies, Division of (99)
  5. GSK Faculty (33)
  6. Executive Committee, Center for Hematologic Malignancies (26)

More Groups

People
  1. Ross Levine (24)
  2. Martin Tallman (23)
  3. Michael Mauro (21)
  4. Eytan Stein (14)
  5. Raajit Rampal (11)
  6. Anthony Mato (9)

More People

Years
  1. 2023 (1)
  2. 2022 (8)
  3. 2021 (6)
  4. 2020 (6)
  5. 2019 (7)
  6. 2018 (10)

More Years

Publications
  1. Haematologica (99)

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer
    Journal Article

    Petrone, G.; Gaulin, C.; Derkach, A.; Kishtagari, A.; Robson, M. E.; Parameswaran, R.; Stein, E. M.
    Haematologica (2023)

    Fulltext@MSK | Save
  • A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib
    Journal Article

    Mato, A. R.; Tang, B.; Azmi, S.; Yang, K.; Zhang, X.; Stern, J. C.; Hedrick, E.; Huang, J.; Sharman, J. P.
    Haematologica (2022)

    Fulltext@MSK | Save
  • Investigational venetoclax combination therapy in acute myeloid leukemia - A systematic review and meta-analysis
    Research Letter

    Shimony, S.; Rozental, A.; Bewersdorf, J. P.; Goldberg, A. D.; Stein, E. M.; Grimshaw, A. A.; Stone, R. M.; DeAngelo, D. J.; Wolach, O.; Stahl, M.
    Haematologica (2022)

    Fulltext@MSK | Save
  • Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia
    Journal Article

    Flynn, K. E.; Atallah, E.; Lin, L.; Shah, N. P.; Silver, R. T.; Larson, R. A.; Pinilla-Ibarz, J.; Thompson, J. E.; Oehler, V. G.; Radich, J. P.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Novel-agent combination therapies in chronic lymphocytic leukemia: The law of relative contributions
    Editorial

    Mato, A. R.; Roeker, L. E.
    Haematologica (2022)

    Fulltext@MSK | Save
  • Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
    Journal Article

    Verstovsek, S.; Mesa, R.; Talpaz, M.; Kiladjian, J. J.; Harrison, C. N.; Oh, S. T.; Vannucchi, A. M.; Rampal, R.; Scott, B. L.; Buckley, S. A.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: A retrospective study based on 286 patients from a single center
    Research Letter

    Liu, D.; Xu, Z.; Zhang, P.; Qin, T.; Sun, X.; Qu, S.; Pan, L.; Ma, J.; Cai, W.; Liu, J.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia
    Research Letter

    Vasu, S.; Altman, J. K.; Uy, G. L.; Tallman, M. S.; Gojo, I.; Lozanski, G.; Burkard, U.; Osswald, A.; James, P.; Rüter, B.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • The impact of early discontinuation/dose modification of venetoclax on outcomes in patients with relapsed/refractory chronic lymphocytic leukemia: Post-hoc analyses from the phase III MURANO study
    Journal Article

    Mato, A. R.; Sharman, J. P.; Biondo, J. M. L.; Wu, M.; Mun, Y.; Kim, S. Y.; Humphrey, K.; Boyer, M.; Zhu, Q.; Seymour, J. F.
    Haematologica (2022)

    Fulltext@MSK | Save
  • All in the family: Back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia
    Editorial

    Thompson, M. C.; Roeker, L. E.; Mato, A. R.
    Haematologica (2021)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: